Skip to main content

Table 2 Vitamin D levels, status, and intake among studied groups

From: Impact of vitamin D status on CF and non-CF bronchiectasis outcomes

  Non-CF bronchiectasis (group I) CF bronchiectasis (group II) Controls (group III) P value Post hoc
Serum vitamin D level, mean ± SD 20.85±7.21 20.15±11.66 35.15±12.84 <0.001 (I vs III) **
(II vs III)**
Vitamin D level status, n (%) Deficient 9(45.0%) 15(75.0%) 2(10.0%) <0.001# (II vs III)** (I vs III)*
Insufficient 8(40.0%) 4(20.0%) 7(35.0%)
Sufficient 3(15.0%) 1(5.0%) 11(55.0%)
Daily dietary intake of vitamin D (IU) (mean ± SD) 338.50±62.17 313.80±65.66 357.25±40.54 0.063 (II vs III) *
Vitamin D dietary intake % of RDA (mean ± SD) 56.42±10.36 56.85±6.90 60.39±9.75 0.467  
Sun exposure, N (%) Adequate 6 (30.0%) 3 (15.0%) 8 (40.0%) 0.552#  
Inadequate 14 (70.0%) 17 (85.0%) 12 (60.0%)
  1. RDA recommended daily allowance. *Significant, **highly significant, ANOVA, #chi-square test